Steven R. Bartz
Rosetta Inpharmatics
LLC, Seattle
WA 98109
USA
Name/email consistency: high
- Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Bartz, S.R., Zhang, Z., Burchard, J., Imakura, M., Martin, M., Palmieri, A., Needham, R., Guo, J., Gordon, M., Chung, N., Warrener, P., Jackson, A.L., Carleton, M., Oatley, M., Locco, L., Santini, F., Smith, T., Kunapuli, P., Ferrer, M., Strulovici, B., Friend, S.H., Linsley, P.S. Mol. Cell. Biol. (2006)
- How will RNAi facilitate drug development?. Bartz, S., Jackson, A.L. Sci. STKE (2005)